CEL-SCI Corp - Asset Resilience Ratio

Latest as of December 2025: 27.45%

CEL-SCI Corp (CVM) has an Asset Resilience Ratio of 27.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of CEL-SCI Corp to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$6.28 Million

Cash + Short-term Investments

Total Assets

$22.89 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2025)

This chart shows how CEL-SCI Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CVM total asset value.

Liquid Assets Composition Over Time

This chart breaks down CEL-SCI Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of CEL-SCI Corp for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$6.28 Million	27.42%
Short-term Investments	$7.09K	0.03%
Total Liquid Assets	$6.28 Million	27.45%

Asset Resilience Insights

Very High Liquidity: CEL-SCI Corp maintains exceptional liquid asset reserves at 27.45% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CEL-SCI Corp Industry Peers by Asset Resilience Ratio

Compare CEL-SCI Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for CEL-SCI Corp (1999–2025)

The table below shows the annual Asset Resilience Ratio data for CEL-SCI Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-09-30	38.93%	$10.96 Million	$28.16 Million	+21.36pp
2024-09-30	17.57%	$4.74 Million	$26.99 Million	+3.99pp
2023-09-30	13.58%	$4.15 Million	$30.53 Million	-31.29pp
2022-09-30	44.87%	$22.67 Million	$50.52 Million	-10.76pp
2021-09-30	55.64%	$42.21 Million	$75.87 Million	+17.38pp
2020-09-30	38.26%	$15.51 Million	$40.54 Million	+7.69pp
2019-09-30	30.57%	$8.44 Million	$27.62 Million	-4.28pp
2018-09-30	34.85%	$10.31 Million	$29.59 Million	+24.51pp
2017-09-30	10.34%	$2.37 Million	$22.92 Million	-16.16pp
2016-09-30	26.50%	$3.07 Million	$11.60 Million	--
2015-09-30	0.00%	$0.00	$15.45 Million	--
2014-09-30	0.00%	$0.00	$19.23 Million	--
2013-09-30	0.00%	$0.00	$10.84 Million	--
2012-09-30	0.00%	$0.00	$16.07 Million	--
2011-09-30	0.00%	$0.00	$18.63 Million	--
2009-09-30	3.44%	$1.59 Million	$46.03 Million	+2.08pp
2008-09-30	1.36%	$200.00K	$14.68 Million	-11.80pp
2001-09-30	13.16%	$593.38K	$4.51 Million	-14.08pp
2000-09-30	27.24%	$3.76 Million	$13.81 Million	-14.87pp
1999-09-30	42.11%	$3.20 Million	$7.60 Million	--

pp = percentage points

About CEL-SCI Corp

NYSE MKT:CVM USA Biotechnology

Market Cap

$12.01 Million

Market Cap Rank

#26672 Global

#5550 in USA

Share Price

$1.42

Change (1 day)

-2.07%

52-Week Range

$1.19 - $10.47

All Time High

$27.64